New Drugs

  Canada NewsWire ZUG,Switzerland,Feb. 11, 2021/CNW/ — MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company announced

PAOG Takes Major CBD Pharmaceutical Development Step Forward  Sandusky, Ohio–(Newsfile Corp. – January 5, 2021) – PAO Group, Inc. (OTC

LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Demonstrated Statistically Significant Improvement in OS, PFS and ORR TOKYO, Dec 17, 2020 –

Eisai: Biogen Files New Drug Application for Aducanumab in Japan TOKYO, Dec 11, 2020 – (JCN Newswire) – Biogen and

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies TOKYO, Nov 30, 2020 – (JCN

 Canada NewsWire LONDON, Nov. 24, 2020 Pharmaceutical clinical industry report highlights factors impacting volume, cost and duration of Phase II